DexCom, Inc. DXCM reported strong preliminary results for the fourth quarter and full-year 2025. Despite the robust ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Connacht team named to play Montauban in the European Challenge Cup. Kick Off tomorrow night in Dexcom Stadium is 8 pm.
DexCom will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.
While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
All four Irish provinces round off their Champions Cup and EPCR Challenge Cup pool stage campaigns this week. Here's ...
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...
Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...
Withings has partnered with Abbott's Lingo CGM to bring glucose monitoring to 15 million users starting Q1 2026 for metabolic ...
The S&P 500 and Dow hit record highs Monday, with tech and Walmart shares climbing despite a Justice Department probe into ...
Shares rose 6.4% to $71.73, putting the stock on pace for its highest close since September, according to Dow Jones Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results